Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
42,805
-3,922
-8% -$119K ﹤0.01% 2888
2026
Q1
$1.32M Hold
46,727
﹤0.01% 2454
2025
Q4
$932K Hold
46,727
﹤0.01% 2653
2025
Q3
$961K Hold
46,727
﹤0.01% 2644
2025
Q2
$785K Sell
46,727
-4,771
-9% -$79.8K ﹤0.01% 2704
2025
Q1
$841K Buy
51,498
+12,972
+34% +$251K ﹤0.01% 2709
2024
Q4
$740K Sell
38,526
-305,477
-89% -$7.45M ﹤0.01% 2833
2024
Q3
$11.7M Buy
344,003
+1,492
+0.4% +$54.7K ﹤0.01% 1513
2024
Q2
$13.4M Buy
342,511
+29,973
+10% +$1.07M ﹤0.01% 1394
2024
Q1
$10.6M Hold
312,538
﹤0.01% 1548
2023
Q4
$9.46M Buy
+312,538
New +$9.22M ﹤0.01% 1615

Other funds holding TRMD

Nuveen's TRMD Position: Q2 2026 in Review

Nuveen reduced its TORM (TRMD) stake by 8.4% in Q2 2026, selling an estimated $119K and leaving 42,805 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2888.

Nuveen first reported a position in TRMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.4M in Q2 2024. 151 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • Nuveen held 42,805 shares of TORM worth $1.1M as of Q2 2026.
  • Nuveen sold 3,922 TORM shares in Q2 2026, an estimated $119K.
  • TORM made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2888 holding.
  • Nuveen first reported a position in TORM in Q4 2023 and has held it in 11 quarters since.
  • Nuveen's TORM position peaked at $13.4M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.